K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients

Cancer Letters

Volumn 115, Issue 1, 1997, Pages 39-46

  Shivapurkar, N ^a   Huang, L ^b   Ruggeri, B ^b   Swalsky, P A ^c   Bakker, A ^c   Finkelstein, S ^c   Frost, A ^d   Silverberg, S ^d  

^a Inst for Chemoprevention Research   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aberrant crypt foci; Colon cancer; K ras; p53

Indexed keywords

METHYLENE BLUE; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; BASE PAIRING; CANCER RISK; CLINICAL ARTICLE; CODON; COLON CANCER; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADENOMA; CARCINOMA; COLONIC NEOPLASMS; GENES, P53; GENES, RAS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PRECANCEROUS CONDITIONS;

EID: 0031148556     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04709-5     Document Type: Article

References (22)

1. [1] Bird, R.P. (1987) Observation and quantitation of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings, Cancer Lett., 37, 147-151.
2. [2] Tudeck, B., Bird, R.P. and Bruce, W.R. (1989) Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods, Cancer Res., 49, 1236-1240.
3. [3] Shivapurkar, N., Tang, Z.C. and Alabaster, O. (1992) The effect of high-risk and low risk diets on aberrant crypt and colonic tumor formation in Fischer-344 rats Carcinogenesis, 13, 887-890.
4. [4] Pretlow, T.P., O'Riordan, M.A., Somich, G.A., Amini, S.B. and Pretlow, T.G. (1992) Aberrant crypts correlate with tumor incidence in F-344 rats treated with azoxymethane and phytate, Carcinogenesis, 13, 1509-1512.
5. [5] Pretlow, T.P., Barrow, B.J., Ashton, W.S., O'Riodan, M.A., Pretlow, T.G., Jucisek, J.A. and Stellato, T.A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa, Cancer Res., 51, 1564-1567.
6. [6] Fearon, E. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis, Cell, 61, 759-767.
7. [7] Fearon, E.R. and Jones, P.A. (1992) Progression towards a molecular description of colorectal cancer development, FASEB J., 6, 2783-2790.
8. [8] Hamilton, S.R. (1992) Molecular genetics of colorectal carcinoma, Cancer, 70, 1216-1221.
9. [9] Pretlow, T.P., Brasitus, T.A., Fulton, N.C., Cheyer, C. and Kaplan, E.L. (1993) K-ras mutations in putative preneoplastic lesions in human colon, J. Natl. Cancer Inst., 5, 2004-2007.
10. [10] Smith, A.J., Stern, H.S., Penner, M., Hay, K., Mitri, A., Bapat, B.V. and Gallinger, S. (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons, Cancer Res., 54, 5527-5530.
11. [11] Barnum, K.M., Hardman, W.E. and Cameron, I.V. (1992) Cell proliferation and aberrant crypt foci distribution near adenocarcinomas in descending colons of dimethylhydrazine (DMH)-treated rats. 4th International Conference on Prevention of Human Cancer: Nutrition and Chemoprevention Controversies Abstract Book, abstract no. 2.
12. [12] McLellan, E.A., Medline, A. and Bird, R.P. (1991) Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions, Cancer Res., 51, 5270-5274.
13. [13] Magnuson, B.A., Carr, I. and Bird, R.P. (1993) Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rat fed cholic acid, Cancer Res., 53, 4499-4504.
14. [14] Shivapurkar, N., Tang, Z.C., Frost, A. and Alabaster, O. (1995) Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and β-carotene in rats on a high-risk diet, Cancer Lett., 91, 125-132.
15. [15] Shivapurkar, N., Tang, Z.C., Ferreira, A., Nasim, S., Garett, C. and Alabaster, O. (1994) Sequential analysis of K-ras mutation in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high risk diet, Carcinogenesis, 15, 775-778.
16. [16] Finkelstein, S.D., Sayegh, R., Christensen, S. and Swalsky, P.A. (1993) Genotypic classification of colorectal adenocarcinoma. Biological behavior correlates with K-ras-2 mutation type, Cancer, 71, 3827-3838.
17. [17] Navone, N.M., Troncoso, P., Pisters, L.L., Goodrow, T.L., Palmer, J.L., Nichols, W.W., von Eschenbach, A.C. and Conti, C.J. (1993) P53 protein accumulation and gene mutation in the progression of human prostate carcinoma, J. Natl. Cancer Inst., 85, 657-669.
18. [18] Lehman, T.A., Bennett, W.P., Metcalf, R.A., Welsh, J.A., Ecker, J., Modali, R.V., Ullrich, S., Romano, J.W., Appella, E., Testa, J.R., Gerwin, B.I. and Harris, C.C. (1991) P53 mutations and p53-heat shock 70 protein complexes in human lung carcinoma cell lines, Cancer Res., 51, 4090-4096.
19. [19] Huang, L., Lang, D., Geradts, J., Obara, T., Klein-Szanto, A.J., Lynch, H.T. and Ruggeri, B.A. (1996) Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines, Mol. Carcinogenesis, 15, 85-95.
20. [20] Zhang, S.Y., Ruggeri, B., Agarwal, P., Sorling, A.F., Obara, T., Ura, H., Namiki, M. and Klein-Szanto, A.J. (1994) Immunohistochemical analysis of p53 expression in human pancreatic carcinomas, Arch. Pathol. Lab. Med., 118, 150-154.
21. [21] Riegelman, R. and Hirsch, R.P. (1989) Studying a Study and Testing a Test: How to Read Medical Literature, Little Brown, Boston, MA.
22. [22] Rumsby, P. and Davies, M. (1995) Genetic events in the development of colon cancer, Food Chem. Toxicol., 33, 328-330.